Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with custom-engineered immune cells that protect them. The goal is to stop the immune system from destroying transplanted cells — without using immunosuppressive drugs. Backed by $1 million in funding, the team hopes to create a ready-to-use treatment that could work even for people who have had diabetes for years. The approach could transform how the disease is treated.
Quelle: ScienceDaily | Allergy
Titelbild/Grafik: ScienceDaily News
Weiteres von ScienceDaily | Allergy
- A bold new plan could finally cure type 1 diabetes
- American Heart Association warns 60% of US women will have cardiovascular disease by 2050
- Shingles vaccine may slow biological aging and reduce inflammation
- Scientists create universal nasal spray vaccine that protects against COVID, flu, and pneumonia
- Scientists discover the body’s hidden “off switch” for inflammation
- This reengineered HPV vaccine trains T cells to hunt down cancer
- Viagra and shingles vaccine show surprising promise against Alzheimer’s
- Scientists discover how life experiences rewrite the immune system
- Why colorectal cancer breaks the immune system’s rules
- New nasal vaccine shows strong protection against H5N1 bird flu
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
